by McDermott + Bull | Dec 11, 2024 | Garrett Lipus Article, Article, Garrett Lipus, Healthcare + Life Sciences, Healthcare + Life Sciences Article
After a subdued start to the year, PE healthcare services investing in Q3 2024 showed early signs of a rebound. Despite a modest dip in deal volume from Q2, with 148 deals announced or closed, investor confidence is slowly returning. Much of the activity focused on...
by McDermott + Bull | Nov 27, 2024 | Ken Dropiewski, Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski Article
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
by McDermott + Bull | Nov 26, 2024 | Noelle Swan, Article, Technology Article
I recently had the pleasure of sitting down with Brian Allen, a seasoned leader and the author of several books on Enterprise Security Risk Management (ESRM), where we discussed the profound changes driven by AI and digitalization that are transforming industries and...
by McDermott + Bull | Nov 21, 2024 | Article, Chris Bull, Chris Bull Article, Private Equity, Private Equity Article
The private equity world is undergoing a fundamental transformation in the way firms approach talent strategy and leadership development. A recent Harvard Business Review analysis reveals why the traditional PE playbook – focused primarily on financial engineering and...
by McDermott + Bull | Aug 16, 2024 | Aaron Griffin, Aaron Griffin Article, Article
Executive leader’s face a myriad of challenges in managing today’s dynamic workforce. Our Partners and Managing Directors in executive search and interim leaders interviewed 14 executive clients to uncover the major factors impacting one of the most common...
by McDermott + Bull | May 22, 2024 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus
Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
